The city of Columbus, Georgia, currently has 1 active clinical trials seeking participants for Type 1 Diabetes research studies.
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Recruiting
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/14/2025
Locations: Centricity Research - Columbus, Columbus, Georgia
Conditions: Diabetes Mellitus, Type 1